25 September 2018Patents

AIPPI 2018: Novartis’s IP protection strategy and warning letters in China

Prevention is better than cure when it comes to IP protection, according to Leticia Leon, regional legal head for Latin America and Canada at pharmaceutical company Novartis.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

Sky v Skykick bad faith ruling to land next week

Bluebird TM dispute shows the answer is nearly always: Put it in writing

Beauty secrets: Why a half-trillion-dollar industry is turning ugly

Douwe Egberts enjoys double shot over Nestlé in coffee patent rivalry

Startup CFO’s betrayal is a lesson in preparing for the worst

President Trump 2.0: Five major areas to watch

The new president will need to get tough on trade secrets

Timing it right: When to raise issues in an IP dispute

AIPPI 2018: Novartis’s IP protection strategy and warning letters in China

Editor's picks

Editor's picks

More articles